Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response

This publication has 23 references indexed in Scilit:

• IL‐12 as a therapeutic target for pharmacological modulation in immune‐mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses
  British Journal of Pharmacology, 1999
• Abnormalities in cord blood mononuclear cytokine production as a predictor of later atopic disease in childhood
  Clinical and Experimental Allergy, 1998
• THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune Responses
  Annual Review of Immunology, 1998
• T1 and T2 CD4+ cells in human allergic diseases
  Journal of Allergy and Clinical Immunology, 1997
• Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Contribution of Intercellular-Adhesion Molecule-1 in Allergen-Induced Airway Hyperresponsiveness and Inflammation in Sensitised Brown-Norway Rats
  International Archives of Allergy and Immunology, 1994
• Interferon‐γ production by cord‐blood mononuclear cells is reduced in newborns with a family history of atopic disease and is independent from cord blood IgE‐levels
  Pediatric Allergy and Immunology, 1993
• The relationship between inflammation and hyperreactivity of the airways in asthma
  Clinical and Experimental Allergy, 1993
• Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes.
  Journal of Clinical Investigation, 1992